MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Montelukast as disease modifying treatment for Parkinson’s disease: a pilot study.

    J. Wallin, P. Svenningsson (Stockholm, Sweden)

    Objective: To assess safety and tolerability of high dose Montelukast as a possible disease modifying treatment for Parkinson’s disease. Background: Emerging evidence suggests that the…
  • 2023 International Congress

    Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.

    K. Andersen, A. Hansen, J. Horsager, K. Knudsen, P. Borghammer (Aarhus, Denmark)

    Objective: The objective of this study was to investigate asymmetric synaptic density and glucose consumption in moderate-stage non demented PD patients and the association between…
  • 2023 International Congress

    Short-term effect of continuous positive airway pressure in MSA patients with sleep disordered breathing

    G. Lazzeri, M. Houot, M. Patout, F. Cormier, M. Vidailhet, JC. Corvol, I. Arnulf, D. Grabli, P. Dodet (Milan, Italy)

    Objective: SBD are frequent in MSA, mainly represented by inspiratory stridor, obstructive and central sleep apnea/hypopnea syndrome (SAS), or hypopneaimpacting the quality of sleep. A…
  • 2023 International Congress

    Combined effect of polygenic background and GBA Pathogenic variants in Parkinson’s disease risk

    Z. Landoulsi, E. Hassanin, S. Pachchek, DB. Bobbili, P. May (Esch-sur-Alzette, Luxembourg)

    Objective: We aimed to investigate whether polygenic background affects the penetrance of Parkinson’s disease (PD) among carriers of heterozygous pathogenic variants (PV) in GBA. Background: Several rare homozygous mutations within…
  • 2023 International Congress

    Primary CNS Lymphoma presenting with Hemichorea Hemiballismus.

    N. Sharma (Chandigarh, India)

    Objective: Completing the list of Hemichorea Hemiballismus apart from stroke and hyperglycaemic states. Background: 61years old female presented with subacute onset abnormal irregular purposeless movements…
  • 2023 International Congress

    Fecal tyrosine decarboxylase and motor response complications in Parkinson’s Disease

    JW. Hor, SY. Lim, TS. Toh, CW. Chong, CSJ. Teh, SL. Song, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the clinical correlates of gut microbe-derived tyrosine decarboxylase (tdc) and motor dysfunction in Parkinson’s Disease (PD) patients. Background: Gut microbe-derived tdc was…
  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • 2023 International Congress

    Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

    R. Ou, C. Li, Q. Wei, K. Liu, J. Lin, T. Yang, Y. Xiao, Q. Jiang, Y. Cheng, Y. Hou, L. Zhang, W. Song, X. Chen, X. Lai, H. Shang (Chengdu, China)

    Objective: Mutations in glucocerebrosidase (GBA) can change the phenotype of Parkinson’s disease (PD). This study aimed to explore the clinical characteristics of freezing of gait…
  • 2023 International Congress

    Predicting ALS progression using remote sensor-based assessments

    D. Anderson, A. Keil, D. Amato, M. Merickel, M. Kantartjis, S. Jezewski, S. Johnson, S. Polyak, B. Severson, J. Severson (Horsham, USA)

    Objective: To develop a predictive model of amyotrophic lateral sclerosis (ALS) progression using self-administered digital assessments. Background: Remote fit-for-purpose sensor-based assessments stand to enhance the…
  • 2023 International Congress

    Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

    Objective: To analyse the gut microbiome and explore dysbiosis in Indian Parkinson’s Disease patients with and without constipation. Background: Global studies have associated gut dysbiosis…
  • « Previous Page
  • 1
  • …
  • 384
  • 385
  • 386
  • 387
  • 388
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley